The U.S. shortage of the chemotherapy drug ifosfamide has reached a “critical” stage, according to an Aug. 25 news release from the American Society of Clinical Oncology.
To address the shortage, the FDA is allowing overseas manufacturers to temporarily import the drug.
In an Aug. 21 letter to healthcare professionals, pharmaceutical company SteriMax USA and its distributor GlobalRX said they will begin importing and distributing vials of ifosfamide.
The imported drug product — Ifosfamide for Injection — is not currently approved by the FDA, the letter said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
